CARMEL,
N.Y., May 15, 2024 /PRNewswire/ -- Dr.
Douglas J. Fauser, a prominent
sports medicine and total joint replacement specialist of the
Somers Orthopaedic Surgery & Sports Medicine Group, along with
Dr. Michael Baroody, a
Board-Certified Plastic Surgeon, have achieved a groundbreaking
milestone in orthopaedic medicine – the first of its kind performed
at the Orthopaedic & Spine Surgery Center (OSSC). On
April 22, they successfully performed
the first autologous live stem cell knee injection using
cutting-edge technology. This revolutionary procedure, conducted
under general anesthesia, involved the administration of purified
concentrated live stem cells derived from the patient's own
abdominal fat.
Dr. Fauser, who has dedicated over 30 years to delivering
high-quality and cost-effective surgical solutions, is leading the
way in non-operative treatments for osteoarthritis. The use of
autologous stem cells represents a significant advancement in
medical treatments, providing patients with an aggressive yet
non-surgical option to manage the debilitating effects of
osteoarthritis in knees.
"We are on the brink of a major shift in how we treat
osteoarthritis," stated Dr. Fauser. "This first-of-its-kind
procedure at OSSC utilizes autologous live stem cells, derived from
the patient's own body, to potentially revolutionize the management
of joint degeneration. Our goal is not just to alleviate symptoms
but to target the underlying causes of osteoarthritis, offering
patients a promising new pathway to recovery without surgery."
Fat tissue, which is known for its cushioning and supportive
roles, contains a high concentration of reparative cells that may
enhance the healing process. The innovative use of microfragmented
adipose tissue, processed by the LIPOGEMS device, exemplifies the
potential of fat to play a critical role in orthopaedic and
arthroscopic surgeries.
The procedure underscores the advantages of using adipose tissue
in orthopaedics, including its minimal invasiveness, abundance, and
superior quality compared to other similar tissues. Research,
supported by over 160 peer-reviewed publications, confirms the
efficacy and safety of using microfragmented fat in various body
areas including shoulders, knees, hips, and feet.
This pioneering treatment by Drs. Fauser and Baroody at OSSC not
only paves the way for future advancements in orthopaedic medicine
but also reinforces the center's commitment to providing innovative
care that adheres to the highest standards of excellence. The
Orthopedic & Specialty Surgery is a leading multi-specialty
surgical facility, located at Somers Orthopaedic Surgery &
Sports Medicine Group's Danbury location, providing outstanding
surgical and patient care for a wide range of musculoskeletal
conditions.
About Somers Orthopaedic Surgery & Sports Medicine
Group
Founded in 1988, the group has been at the forefront of
diagnosing and treating musculoskeletal conditions. It is staffed
by board-certified physicians specializing in various orthopaedic
disciplines. For more details, visit
somersortho.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/dr-douglas-fauser-of-somers-orthopaedic-surgery--sports-medicine-group-conducts-first-autologous-live-stem-cell-knee-injection-at-ossc-offering-new-hope-for-osteoarthritis-patients-302146599.html
SOURCE Somers Orthopaedic Surgery & Sports Medicine
Group